Status | Study |
Recruiting |
Study Name: Variables That Are Correlated to Developing Multiple Endocrine Neoplasia (MEN) and Pancreatic Neuroendocrine Tumors (PNET) Condition: Multiple Endocrine Neoplasia Pancreatic Neuroendocrine Tumors Date: 2017-02-13 Interventions: Other: Genome Sequencing Analy |
Recruiting |
Study Name: Overall and Disease Specific Survival in Patients With Confirmed MEN1 With or Without PNET (Pancreatic Neuroendocrine Tumors) Condition: Genetic Mutation MEN1 Date: 2017-02-02 Interventions: Other: Chart Review Database r |
Recruiting |
Study Name: Phase IV Study of the Safety and Efficacy of Everolimus in Adult Patients With Progressive pNET in China Condition: Pancreatic Neuroendocrine Tumors Date: 2016-06-16 Interventions: Drug: everolimus Everolimus is taken at a starting dose of 10 mg orally once daily.Patients will be prov |
Not yet recruiting |
Study Name: Phase II Study to Evaluate Efficacy of Rechallenge With Sunitinib in Patients With Metastatic Pancreatic Neuroendocrine Tumor (pNETs) Who Previously Failed to Sunitinib Condition: Pancreatic Neuroendocrine Tumour Metastatic Date: 2016-03-16 Interventions: Drug: Sunitinib Sunitinib 37.5 mg/day |
Active, not recruiting |
Study Name: A Trial to Assess the Activity and Safety of Palbociclib in Patients With Well and Moderately Differentiated Metastatic Pancreatic Neuroendocrine Tumors (pNET) Condition: Pancreatic Neuroendocrine Cancer Date: 2015-07-08 Interventions: Drug: Palbociclib Palbociclib Other Name: palbocicli |
Recruiting |
Study Name: A Study to Assess the Safety and the Efficacy of the Combination of TH-302 and Sunitinib in Neuroendocrine Pancreatic Tumours Condition: Neuroendocrine Tumors Pancreatic Neoplasms Date: 2015-02-26 Interventions: Drug: TH-302 + Sunitinib Combination of the two drugs in c |
Terminated |
Study Name: Phase I/II: Decitabine/Vaccine Therapy in Relapsed/Refractory Pediatric High Grade Gliomas/Medulloblastomas/CNS PNETs Condition: Gliomas Medulloblastoma Neuroectodermal Tumors, Primitive Date: 2014-10-20 Interventions: Biological: Vaccine (autologous dendritic cells) |
Recruiting |
Study Name: Observational Study In Real Life Settings Of The Systemic Treatment Of Well Differentiated, Unresectable Or Metastatic, Progressive Pancreatic Neuroendocrine Tumors (pNET): A Study Of Morbidity And Mortality At 2 Years Condition: Pancreatic Neuroendocrine Tumor, Well Differentiated and Progressive Date: 2014-09-02 Interventions: Drug: sunitinib sunitinib 37.5 |
Recruiting |
Study Name: Efficacy and Safety of Everolimus and (STZ-5FU) Given One Upfront the Other Upon Progression in Advanced pNET Condition: Pancreatic Neuroendocrine Tumours. Date: 2014-08-20 Interventions: Drug: Drug: Everolimus 10mg/da |
Recruiting |
Study Name: International Society of Paediatric Oncology (SIOP) PNET 5 Medulloblastoma Condition: Brain Tumors Date: 2014-02-07 Interventions: Radiation: Radiotherapy without Carboplatin |